Immunotech Biopharm Ltd

Please note that due to the planned shutdown of Webb-site.com, the directors, officers and advisers of HK-listed companies have ceased to be updated effective 2025-03-31. Appointments and resignations effective on or before that date were recorded, as were advisers recorded in annual reports filed on or before that date. A repository of our database and software is now available.
Snapshot date:
exclude unknown removal dates

Main board

Some data are hidden to fit your display. Rotate?

Row Director Position From Until
1 Jung, Hyun Chul (1961) EDExecutive Director 2019-08-23 2023-03-24
2 Li, Yuezhong (1969) NEDNon-Executive Director 2019-08-23 2021-08-23
3 Lu, Yuan (1989) NEDNon-Executive Director 2019-08-23 2023-03-24
4 Ng, Chi Kit (1973) INEDIndependent Non-Executive Director 2020-06-29 None
5 Peng, Sujiu INEDIndependent Non-Executive Director 2020-06-29 None
6 Si, Xiaobing NEDNon-Executive Director 2019-08-23 2023-08-25
7 Tan, Zheng (1977) ChChairman 2018-04-11 None
8 Tao, Ran (1966) NEDNon-Executive Director 2021-08-23 None
9 Wang, Donghu NEDNon-Executive Director 2023-08-25 None
10 Wang, Ruihua (1963) NEDNon-Executive Director 2023-03-24 None
11 Wang, Yingdian INEDIndependent Non-Executive Director 2020-06-29 None
12 Wang, Yu (1967-07) CEOChief Executive Officer 2019-08-23 None
13 Yang, Fan (1980) NEDNon-Executive Director 2023-03-24 None

Manager/adviser/other

Some data are hidden to fit your display. Rotate?

Row Director Position From Until
1 Chen, Ran (immunotech) CoSecCompany Secretary 2024-07-26 2024-12-02
2 Leung, Shui Bing CoSecCompany Secretary 2024-07-26 None
3 Leung, Shui Bing CoSecCompany Secretary None 2021-08-23
4 Yang, Ning (1981) CFO, CoSecChief Financial Officer, Company Secretary 2021-08-23 2024-07-26
5 Yin, Mengyang CoSecCompany Secretary 2019-08-23 2021-08-23

Powered by Renavon Data — Hong Kong financial data services, built on Webb-site.com datasets (CC-BY 4.0)


Sign up for our free newsletter

Recommend Renavon Hong Kong to a friend

Copyright & disclaimer, Privacy policy

Back to top